Psychemedics has approved a transition plan for the company’s President and CEO position. Effective August 17th, current Chairman of the Board, President, and CEO, Ray Kubacki, will retire from the positions he holds and be succeeded by Brian Hullinger as President and CEO. Subject to shareholder approval, Hullinger will also join the company’s board of directors. Kubacki will remain with the company in an advisory role for a period after August 17. . Hullinger has held leadership positions including CEO, head of global sales and marketing, and CRO at several tech-enabled service organizations. Kubacki joined the company in 1991 as its President and CEO. He was appointed Chairman of the Board in 2003. Fred Weinert informed the company he is retiring as a director at the expiration of his current term at the 2023 annual meeting of stockholders. After his retirement, the board will be comprised of five members.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PMD: